SCHEMBL24599861

SCHEMBL24599861

CCOC(=O)C(CN)C(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.54
ALDH1A1 P00352 5/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
LMNA P02545 2/20 0.50
TDP1 Q9NUW8 2/20 0.48
KMT2A Q03164 3/20 0.46
MAPK1 P28482 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
PIN1 Q13526 1/20 0.45
TP53 P04637 1/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 2/20 0.45
HSD17B10 Q99714 2/20 0.44
NPY1R P25929 1/20 0.44
NPY2R P49146 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27696619 0.87 ALDH1A1 (0.51) ALDH1A1L3MBTL1TDP1KMT2AMAPK1
SCHEMBL7060682 0.87 MMP8 (0.56) MMP8ALDH1A1L3MBTL1LMNATDP1
SCHEMBL27801418 0.87 ALDH1A1 (0.50) ALDH1A1L3MBTL1LMNATDP1KMT2A
SCHEMBL11195047 0.86 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNATDP1KMT2A
SCHEMBL27748674 0.86 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNATDP1KMT2A
SCHEMBL27452191 0.86 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNATDP1KMT2A
Hydrochloric Acid SCHEMBL4263027 0.86 ALDH1A1 (0.50) MMP8ALDH1A1L3MBTL1TDP1KMT2A
Hydrochloric Acid SCHEMBL4263030 0.86 ALDH1A1 (0.50) MMP8ALDH1A1L3MBTL1TDP1KMT2A
SCHEMBL27371886 0.85 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNATDP1KMT2A
Hydrochloric Acid SCHEMBL27576626 0.85 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNATDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213060-A1 Crystal Form of Quinazolinone Compound and Preparation Method Therefor Luoxin Healthcare Science and Technology Development (Beijing) Ltd. (CN) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213060-A1 Crystal Form of Quinazolinone Compound and Preparation Method Therefor WEE1, PIK3CA, PIK3CD MMP8 2957/4885ALDH1A1 3049/4885L3MBTL1 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.